Market & Regulation
Backlash Grows Against AI Data Centers
Music Tech Policyhigh confidence
Why it matters
- →The backlash highlights the tension between AI infrastructure development and community rights.
- →Microsoft's decision to stop using NDAs could influence industry practices towards greater transparency.
- →The movement unites diverse groups, indicating widespread concern over AI's local impacts.
A growing backlash against AI data centers is uniting diverse groups across the U.S., including property-rights advocates and environmentalists. Key issues include the use of eminent domain, secrecy through NDAs, and the erosion of local control. In Coweta County, Georgia, a family's home was demolished for infrastructure, symbolizing the human cost of AI development. Microsoft has stopped requiring NDAs from local governments, challenging the notion that secrecy is essential for data center projects. This movement underscores the need for transparency and public involvement in AI infrastructure decisions.
Read originalMore in Market & Regulation
© SiftedInvestment · $700M
Market & Regulationbusiness
Neko Health raises $700M Series C funding
Neko Health has successfully raised $700 million in Series C funding, marking a pivotal moment for the company. With 100,000 members and profitability at the clinic level, this funding round is a testament to the company's robust growth and operational success. The investment is set to drive further expansion and innovation in their healthcare services, potentially reshaping the landscape of healthcare delivery. Neko Health's strategic position in the health tech industry is strengthened by this substantial financial backing, which reflects strong investor belief in its business model and future trajectory.
Sifted
© SiftedInvestment · $15M
Market & Regulationbusiness
Meticulous raises $15M to enhance AI code testing
Meticulous, a London-based startup, has secured $15 million in Series A funding to advance its AI-driven code testing platform. Founded by ex-Palantir and Dropbox engineers, the company aims to streamline the process of verifying AI-generated code by simulating user flows and identifying edge cases. This approach allows developers to quickly understand the impact of code changes, potentially accelerating the deployment process. With plans to expand into backend testing and grow its team, Meticulous is positioning itself as a key player in the AI code verification space.
Sifted
© TechCrunch AIInvestment · $200M
Market & Regulationbusiness
OpenAI's Miles Wang plans $2B AI drug startup
Miles Wang, an OpenAI researcher, is reportedly leaving to start a new AI-driven drug discovery company, potentially valued at $2 billion. This move highlights the growing trend of applying AI to accelerate breakthroughs in life sciences, with Wang's startup aiming to repurpose existing drugs for new uses. While the funding details are still in flux, the interest from investors like Lightspeed shows the potential impact of AI in the pharmaceutical industry. If successful, Wang's venture could significantly reduce the time and cost associated with bringing new treatments to market.
TechCrunch AI